• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • BioAsia 2023 to be held in February 24-26 in Telangana, India
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian?
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE
  • Event: Australia’s biggest week in biotech kicks off in Perth
  • $3 trillion growth reported for biotech sector in USA
  • Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect”
  • Vaccination, Rising Deaths, And The False Narrative
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    July 26, 2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Articles»Why Only 10 Indians on list of world’s 4,000 top scientists: Explained by Dr. Ashok Pandey, who secured a place in the list

Why Only 10 Indians on list of world’s 4,000 top scientists: Explained by Dr. Ashok Pandey, who secured a place in the list

0
By Biotech Express on February 6, 2019 Articles, Biotech News, Interviews, Interviews - Academia

Scientist Dr. Ashok Pandey, is in the list of World’s most influential scientist in the world along with nine other Indian scientists. The report is prepared by Clarivate Analytics. Dr. Pandey is the only scientist from CSIR and working in CSIR-IITR Lucknow. I have contacted Dr. Pandey to understand about the various aspects of reports.

First of all congratulations to you for this great recognition. Definitely you deserve it, as I have seen you CV and it is having huge lists of your work either in form of research article, books or other related activities.
Q- Highly Cited Researchers (HCRs), what it means to non scientific people or laymen?

Scientist Dr. Pandey: This in a way shows that the research and technological developmental work done by the person has been highly read by the community which found it of great relevance for them; then they followed it for their won works and referred it in their papers.

Q- Is HCRs report is free from limitations or this too has similar to ongoing debate of judging the working on the basis of impact factor or number of article v/s quality of article?

Scientist Dr. Pandey: For sure there can be endless debate and arguments and various issues can be raised (even just for the sake of raising the issues!) but it is well proven and accepted that the methodolo

gy adopted for this is perhaps the best. In fact, globally it has widest recognition.

Q- What you think about this report, it will be helpful for scientific community around the globe?
Scientist Dr. Pandey: Yes, it is of not just only of great relevance for individuals (great recognition), it helps overall the community to network and collaborate (based on the common interests and to compliment the expertise).

Q- You are the only scientist from CSIR, world’s largest scientific organizations having more than 5000 scientists, in the list of Highly Cited Researchers? It seems that somewhere is problema or limitations either in CSIR or in the methodologies followed by Clarivate Analytics while preparing the HCRs lists?

Scientist Dr. Pandey: As I have mentioned above, the methodology adopted by the Clarivate Analytics is the best one- at least now (tomorrow there may be possibilities of some other better methods); this is un-disputed method globally. In fact, if you look at various other kinds of scales, which are used to rank, for example, universities, institutes, etc globally, similar reflection we find for us (for Indian universities and institutes); we should resist to blame others and try to do truthful analysis/introspection and take remedial actions.

It’s not easy to summarize in one sentence the reasons for the poor performance of Indian scientist in the list (of for that matter that of CSIR scientists) but let me try to tell you in my individual/personal capacity (which of course is based on my professional experience as an individual and also as global traveler for professional works/collaboration).

Let us see about CSIR alone. At times, we encourage to publish; then suddenly someone decides ‘we don’t want publication’; “we just want technologies”. There are people –at top management who even used (impolite) statements like ‘we don’t want PAPER SCIENTIST’. What is most pity that such statements and changes in stance have often been related with the policies of government (central government), which perhaps is never true. For any government obviously the most important agenda would be welfare of the people. For the development, govt would want to take the help from the scientists of the country for ways to improve the health, hygiene, good, infra-structure development, etc. That means scientific knowledge developed by the scientists should have avenues for its utilization as technologies, etc. No govt said that you don’t do good science! It is the people who mis-conducted themselves in leadership roles and mis-governed the scientific community.

For any scientist, the bottom line is to do good science; good science needs to be known to the people (for which avenue is paper publication). Note that its highly completive world for quality publications as well. Thus, at no point of time, it should be point blank discouraged. Then, the second aspect, which is important for the scientist is to carefully evaluate the findings – individually and/or through institutional team to identify if any of the results could be of technological relevance. Such results should be protected (patenting) and then look for industrial avenues for these. Note that every work cannot be high quality science or patentable results; also, note that some scientists would always like to do works directly related with the society, such as environmental programs, or modern farming, etc, which too are of extremely relevance. These should not be neglected.

I am very happy that at least now, the new DG of CSIR, Dr Mande has put the policy framework and working goals for CSIR scientists very clearly. In his message to CSIR community on 1st January 2019, he mentioned about the three aspects, which included science for society, doing good quality science (and to publish) and explore/exploit the work for technological developments. The message is very clear.

Having said all above, I would also want to briefly touch upon one another issue. In fact, honestly telling this could be even controversial but I am putting straight forward fact to you. One very critical issue, which is in some way responsible for not high quality publications or technological developments coming out is directly related with the manpower quality we have. We see that large number of highly meritorious scholars do not get job, while much less meritorious get! Then, how should you expect the ‘high quality science’ from them?

Q- Scientist CNR Rao told Time of India that 15 years back China and India were at same level but now China (15-16%) is contributing far more in World science then India (3-4%). Mean time, Indian academics became leader in publishing the fake research. What went wrong with both the cases India and China?

Scientist Dr. Pandey: I would not like to comment on who said what but would elaborate more here what I just said in last above. I do not believe so-called ‘blame-game’; I never did it any time in my professional career (note that I am just one; you would find n number of such people who would want to work, rather not getting involved in gossip-groups, which are very popular in CSIR institutes).

In a sting operation a few years ago, two professors from Wisconsin University created a large number of fake research manuscripts based on 7th and 8th standard science books and sent them for publication in some 250 open access journals (mostly having very modern and fancy names); to sum-up the story majority of these journals accepted large majority of these ‘papers’ within seven days. Whatever above, now the fact is this that many-many Indian researchers, including from those whom we call as ‘premier institutes’ are too happy to publish in those journals. Who is responsible scientist/professor? Or, the student? To me, the onus lies on former ones.

Now I will comment specifically on the question with China. In China (and many other countries, including South Korea), there is internal recognition system. If a professor/scientist publishes one paper in a Q1 journal (based on impact factor and h index, journals are classified, in which Q1 is highest), he/she is given cash intensive for this (which he can share with all co-authors). The amount for various countries varies and it could be as high as US$ 1200-1500 per paper. I am not asking to simply follow what others are doing but at least we can stop discouraging the scientists.

Q- When I talked about Ease of Doing Science in India, similar to Ease of Doing Business, few scientists recommended liberalizing the lateral entry for Indian researcher working abroad setup lab in India and removing the age limit in recruitment of scientists.

1- What do you think about these recommendations and

2- What types of measures you would recommend to improve the Ease of Doing Science with quality in India?

Scientist Dr. Pandey: I would not be shy to tell that firstly we need to learn to respect the merit. Absolute efforts should be made to recruit meritorious scholars (note that I do not mean that this is not happening; for sure this is happening but only a small portion). I do not (fully) agree that there is no environment for doing Ease of Science in India; there are hurdles but still it is happening. As far age limit, there are different levels of scientist, for example in CSIR (same for any other organization), where age limit is different for different level).

Recruit meritorious people with open grading system based on credentials and institutional requirement,

Allowing to establish individuals to do science of their choice with a set potion of time and rest time for the institution project with team building. The former one to see/allow for a given period (not open ended).

Emphasis on team work with defined and quantifiable goals.

Objective based evaluation (no subjectivity at all) for career growth.
Incentives based on performance.

Q- As you are recipient of Shanti Swaroop Bhatnagar Prize and veteran scientist, Please make a comment on below query. I have also contacted with other concerned authority dealing with Shanti Swaroop Bhatnagar Prize.

what is the logic or reason behind putting the 45 age limit for considering a candidate for India’s highest multidisciplinary science awards for Science and Technology. The other different awards either of a particular field such as sports or films or padma awards etc (as far as I know) they do not have the age limit criteria for conferring award to any eligible candidate.

Scientist Dr. Pandey: Sorry; I am not recipient of SSB prize.

Thank your once again sir, for sparing time for answering the queries. I am hopeful that this will help the scientific community in one way or other way.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Praj Industries and ESIIC partner to further bioeconomy in Egypt

Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian?

Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE

Leave A Reply Cancel Reply

Current Issue – October 2022
Upcoming Event

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • BioAsia 2023 to be held in February 24-26 in Telangana, India January 10, 2023
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt November 10, 2022
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian? November 1, 2022
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE October 31, 2022
  • Event: Australia’s biggest week in biotech kicks off in Perth October 26, 2022
  • $3 trillion growth reported for biotech sector in USA October 25, 2022
  • Event : FABA’s Whale Tank Event – “Venture Capital – Biotech Start-up Connect” September 21, 2022
  • Vaccination, Rising Deaths, And The False Narrative September 20, 2022
  • Guestorial: Genome Mapping Techniques and its Application in Aquaculture September 19, 2022
  • Bombay HC Issues Notice To Bill Gates, Serum Institute, DGCI, Others Over Plea On Alleged ‘Vaccine Death’ September 5, 2022
  • Deaths due Covid-19 vaccines should be compensated by vaccine makers: Expert hope on Kerala HC remark August 21, 2022
  • Maker of Dolo-650, pandemic’s ‘magic pill’, faces income tax searches and PIL petitions August 20, 2022
  • Anthony Fauci, Controversial US Top-doc FINALLY, To Retire By Year-end August 20, 2022
  • SII’s Cervevac: The new DCGI approved vaccine without published clinical trial results August 20, 2022
  • Pitch your Start-up to National/International Venture Capitalists – first ever opportunity provided to Bio-Start-ups by FABA August 19, 2022
  • India’s Clinical Trial Registry might disappear soon and so the history of pharma record August 19, 2022
  • Nearly Half of Pregnant Women in Pfizer Trial Miscarried August 10, 2022
  • Researchers develop Cellulose shoes made by bacteria August 9, 2022
  • Biocon Sdn. Bhd. Enters Malaysia Book of Records as the First & the Largest Integrated Insulin Manufacturing Facility August 5, 2022
  • CBI Arrests of CDSCO officials, a Biocon official & Intermediaries in an alleged bribery case exposed Corruption in Govt and Pharma sector July 27, 2022
  • We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO July 26, 2022
  • EVENT HIGHLIGHTS: Genome editing as a novel technology for sustainable development July 24, 2022
  • US Military Doctor Testifies under Oath That She Was ORDERED To ‘Cover up’ COVID Vaccine Injuries July 24, 2022
  • Climatic Effect on Marine Biodiversity and their impact on coral reefs July 23, 2022
  • Highlights of India’s first Biotech startup Expo June 13, 2022
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity June 6, 2022
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds May 30, 2022
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft May 26, 2022
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak May 25, 2022
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid May 25, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.